-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓USDISIN JE00BYSS4X48-
NOVOCURE LTDBörse Börse BerlinEURSymbol 038
-
NOVOCURE LTDBörse Quotrix System der Börse DüsseldorfEURSymbol 038
-
NOVOCURE LTDBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 038
-
NOVOCURE LTDBörse Börse StuttgartEURSymbol 038
-
NOVOCURE LTDBörse Gettex System der Börse MünchenEURSymbol 038
-
ISIN JE00BYSS4X48 WKN: A140MLUSDSymbol NVCR
-
EURSymbol 038
-
EURSymbol 038
-
EURSymbol 038
-
ISIN JE00BYSS4X48
WKN A140ML
Symbol NVCR
Währung
USD
Firmenname
NovoCure Limited
Marktkapitalisierung
15.849.277.440 (+- 11%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
14.162.554.880 oder 17.536.000.000
Mitarbeiter
1.172 (+- 13%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.023 oder 1.320 Mitarbeiter
KGV
768.28
EBITDA 38.562.000
PEGRatio -0.47
Buchwert 4.657
NovoCure Ltd outperformed den DAX um +1052 % vom 01.10.2015 bis 21.06.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 168,95 EUR -0,17%
Entdecke die 6 ETFs in denen NovoCure Limited am höchsten gewichtet ist Insgesamt in 29 ETFs enthalten
Dir gefallen die Informationen zu NovoCure Ltd?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu NovoCure Ltd?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu NovoCure Ltd?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu NovoCure Ltd?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
46 News & Informationen zur NovoCure Ltd Aktie
NovoCure EPS misses by $0.15, misses on revenue (NASDAQ:NVCR)
NovoCure (NVCR): Q2 GAAP EPS of -$0.14 misses by $0.15.Revenue of $133.5M (+15.2% Y/Y) misses by $8.34M.Quarterly net revenues of $133.5 million, presenting 15% growth versus the…
Were Hedge Funds Right About Leidos Holdings Inc (LDOS)?
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting…
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…
Top Healthcare Stocks to Watch for 2021
Check out Top Healthcare Stocks to Watch for 2021 by Bohen's team at StocksToTrade read more.
Here is What Hedge Funds Think About Loews Corporation (L)
In this article we will check out the progression of hedge fund sentiment towards Loews Corporation (NYSE:L) and determine whether it is a good investment…
4 Overvalued Healthcare Stocks to Avoid By StockNews
4 Overvalued Healthcare Stocks to Avoid
Hedge Funds Keep Betting On NICE Ltd (NICE)
In this article we will analyze whether NICE Ltd (NASDAQ:NICE) is a good investment right now by following the lead of some of the best investors in the…
NovoCure (NASDAQ:NVCR): High-Income Options Trade, Bullish Vertical Put Spread
NovoCure is an attractive, high-growth, oncology company with a large market opportunity. Read more to know why we like NovoCure as a long-term investment.
NovoCure Slump To Continue
Stocks Analysis by EWM Interactive covering: Novocure Ltd. Read EWM Interactive 's latest article on Investing.com
Mid-Afternoon Market Update: Dow Gains 100 Points; NovoCure Shares Plunge
Toward the end of trading Thursday, the Dow traded up 0.29% to 34,603 while the NASDAQ rose 0.01% to 14,504.68. The S&P also rose, gaining 0.44% to …
Why Novocure Stock Is Sliding Today
Investors hoped for better results from the company's phase 2 study.
Sarepta, Vertex, Neurocrine: There’s Deep Value In These Beaten Down Healthcare Stocks
Our theme of Out Of Favor Health Care Stocks includes healthcare and pharma names that are seeing a disconnect between their financial performance and stock price returns. Specifically, the theme filters for healthcare companies that have grown revenue by at least 50% over the last three years…
Novocure : Presents Final Safety and Efficacy Results from its Phase 2 Pilot HEPANOVA Trial in Liver Cancer
Disease control rate was 76% with 9.5% objective response in a patient population with poor prognosis and limited exposure to study treatments
In patients who completed at least 12 weeks of Tumor… | July 1, 2021
Asahi Intecc : Notice Regarding the Change of the Company Name (New Trade Name) of the Consolidated Subsidiary
2021/07/01Notice Regarding the Change of the Company Name of the Consolidated Subsidiary
Asahi Intecc announces that it passed a resolution at its board of directors' meeting… | July 1, 2021
Zacks.com featured highlights include: Manchester United, NovoCure, Palantir Technologies and JD.com
Zacks.com featured highlights include: Manchester United, NovoCure, Palantir Technologies and JD.com
Up 1,100%, This Cancer-Fighting Stock Has Room To Run
NovoCure's unique treatment for cancerous tumors is both a medical breakthrough and an investment opportunity.
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (…
Potential Game-changing Bio-Technology
There are some exciting developments in the biotech arena that could potentially be game-changers in their respective fields.
NIRI Philadelphia Elects New Board Members
The Philadelphia Chapter of the National Investor Relations Institute announced that its members have elected the following individuals to serve on the Board of Directors for a twelve-month term…
What’s Next For Novocure Stock?
Over the past few months we have discussed why Novocure stock (NASDAQ: NVCR) was vulnerable to downside risk, given its large rally and a delay in clinical trials.
NovoCure: Why It's Still Worth Buying (NASDAQ:NVCR)
Yesterday, NovoCure's stock price made a huge jump of 50% because of an update of its LUNAR study. We look at how its TTF technology works and what it means for NovoCure's TAM.
Here is a Market Recap for today Wednesday, August 14, 2021 : stocks
PsychoMarket Recap – Wednesday, April 14, 2021 Stocks traded mixed on Wednesday, with the Dow Jones rallying to intraday highs while the S&P 50 …
Novocure Shares Climb 50% on Acceleration of Phase 3 Lung Cancer Trial
Coinbase, JPMorgan Chase, ConocoPhillips: What to Watch When the Stock Market Opens Today
Cryptocurrencies including bitcoin and ether jumped ahead of Coinbase Global's trading debut.
NovoCure (NVCR) Moves 49.6% Higher: Will This Strength Last?
NovoCure (NVCR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Cramer's Mad Money Recap: Coinbase, Johnson & Johnson
It takes critical thinking to be a good investor, Jim Cramer says. Here's why he took money out of the market for his charitable trust.
Why Novocure Stock Skyrocketed Today
The oncology specialist's investigational cancer treatment could be a game-changer.
Danaher, Novocure rise; Amarin, American Airlines fall
Stocks that traded heavily or had substantial price changes Tuesday: Danaher, Novocure rise; Amarin, American Airlines fall
Danaher, Novocure rise; Amarin, American Airlines fall
Stocks that traded heavily or had substantial price changes Tuesday:
US stocks rise, shrugging off inflation concerns and J&J vaccine halt
Deutsche Bank said retail investors have been key players in the stock market rally Johannes Eisele/Getty Images US shares closed higher on Tu…
Mid-Afternoon Market Update: Dow Falls 75 Points; vTv Therapeutics Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 0.22% to 33,669.76 while the NASDAQ rose 0.80% to 13,960.92. The S&P also rose, gaining…
Independent Monitors Suggest Shorter Timeline for Novocure's Lung Cancer Treatment
A trial examining the use of Novocure's tumor-treating field technology in non-small cell lung cancer patients could enroll fewer patients over a shorter period, based on recommendations by an independent committee.
Best Biotech Penny Stocks to Buy Today? 3 to Watch Right Now
NovoCure surges 65% to all-time high on upbeat review of its lung cancer treatment trial
In this photo illustration, a NovoCure Ltd logo seen displayed on a smartphone. Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via…
EDGAR Filing Documents for 0001645113-21-000052
Are Options Traders Betting on a Big Move in NovoCure (NVCR) Stock?
Investors need to pay close attention to NovoCure (NVCR) stock based on the movements in the options market lately.
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
Noteworthy Points: Taiwan Semiconductor (NYSE:TSM) was the largest firm on a …
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ja…
BioMarin, Alkermes, Ionis: Are These Health Care Stocks Set To Outperform In 2021?
Our theme of Out Of Favor Health Care Stocks includes health care names that have witnessed strong growth and improving fundamentals over the last few years but have still underperformed over 2020, partly due to Covid-19 related disruptions of the health care industry…